Abstract
Here we review the paradigm-change from one-size-fits-all psychiatry to more personalized-psychiatry, where we distinguish between 'precision psychiatry' and 'stratified psychiatry'. Using examples in Depression and ADHD we argue that stratified psychiatry, using biomarkers to facilitate patients to best 'on-label' treatments, is a more realistic future for implementing biomarkers in clinical practice.
Original language | English |
---|---|
Pages (from-to) | 14-19 |
Number of pages | 6 |
Journal | European Neuropsychopharmacology |
Volume | 55 |
Early online date | 9 Nov 2021 |
DOIs | |
Publication status | Published - Feb 2022 |
Keywords
- ADHD
- ASYMMETRY
- Biomarker
- DEPRESSION
- Depression
- EEG
- Precision psychiatry
- Stratified psychiatry